PTCH1 and medulloblastoma: Originally, the HH-GLI signaling pathway was targeted at the level of SMO, in an attempt to bypass the inactivating PTCH1 and activating SMO mutations often found in Hedgehog-associated tumors like medulloblastoma and basal cell carcinoma.